
MANHASSET, N.Y., June 2 (UPI) -- U.S. researchers found the antidepressant drug citalopram was no better than a placebo in treating autism behavior such as spinning or rocking.
The multicenter, 12-week clinical trial involving 149 children ages 5-17 was directed by the Feinstein Institute for Medical Research in Manhasset, N.Y.
The researchers suggest the study, published in the Archives of General Psychiatry, should serve to reduce the number of antidepressant prescriptions written for children with autism and similar conditions on the autism spectrum.
"We can't rely on apparent similarities to other conditions and clinical experiences to guide our treatment strategies," Dr. Joel Bregman, the study investigator, said in a statement. "This was a large, double-blind clinical trial that showed that this class of medicine is not effective in reducing these behaviors."
The researchers noted the placebo response was very high. One in three children in both groups -- 32.9 percent treated with citalopram and 34.2 percent treated with placebo -- were reported to have fewer or less severe symptoms.
|
|
|
| Additional Health News Stories | |
TACOMA, Wash., Feb. 9 (UPI) --
The mother of Josh Powell, who killed himself and his sons in a fire in Washington state, said in divorce papers he exhibited disturbing behavior as a teenager.
|
NEW YORK, Feb. 9 (UPI) --
Macaulay Culkin is in "perfectly good health," his publicist said after the former child star was photographed looking gaunt and disheveled in New York.
|
XINXIANG CITY, China, Feb. 9 (UPI) --
A set of parents in China said they expected a large baby, but they were shocked when their son came out weighing a potentially record-setting 15 1/2 pounds.
|
WASHINGTON, Feb. 9 (UPI) --
President Obama hailed a $25 billion agreement among 49 states, the U.S. government and the five biggest mortgage servicers.
|
| Stories | Photos | People | Comments |
View Caption